Cbl suppresses B cell receptor-mediated phospholipase C (PLC)-γ2 activation by regulating B cell linker protein-PLC-γ2 binding

Journal of Experimental Medicine

Volumn 191, Issue 4, 2000, Pages 641-650

  Yasuda, Tomoharu ^a   Maeda, Akito ^b   Kurosaki, Mari ^b   Tezuka, Tohru ^a   Hironaka, Katsunori ^a   Yamamoto, Tadashi ^a   Kurosaki, Tomohiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adaptor molecule; Antigen receptor; Lymphocyte; Negative regulator; Signaling

Indexed keywords

B LYMPHOCYTE RECEPTOR; LINK PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; ONCOPROTEIN; PHOSPHOLIPASE C;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CARRIER PROTEINS; CHICKENS; ENZYME ACTIVATION; GENOMIC LIBRARY; HUMANS; ISOENZYMES; KARYOTYPING; MUTAGENESIS, SITE-DIRECTED; ONCOGENE PROTEIN V-CBL; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHOSPHOPROTEINS; RECEPTORS, ANTIGEN, B-CELL; RECOMBINANT PROTEINS; RETROVIRIDAE PROTEINS, ONCOGENIC; SIGNAL TRANSDUCTION;

EID: 0034695890     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.4.641     Document Type: Article

References (67)

1. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif
2. V-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas
3. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene
4. C-Cbl: A regulator of T cell receptor-mediated signalling
5. Cbl: Complex formation and functional implications
6. The c-Cbl oncoprotein
7. The Cbl family of signal transduction molecules
8. T cell antigen-receptor signal transduction
9. 292 negative regulatory phosphorylation site of ZAP-70
10. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase
11. Modular peptide recognition domains in eukaryotic signaling
12. Physical and functional association of the cbl protooncogen product with an src-family protein tyrosine kinase, p53/56(ly11), in the B cell antigen receptor-mediated signaling
13. The SH3 domain-binding T cell tyrosyl phosphoprotein p120
14. Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein
15. Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells
16. P120(cbl) is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase
17. Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fcγ receptors
18. Association of tyrosine protein kinase Zap-70 with the protooncogene product p120(c-cbl) in T lymphocytes
19. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase
20. The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor
21. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G
22. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins
23. Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rap1
24. Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene
25. Specific association of phosphatidylinositol 3-kinase with the protooncogene product Cbl in Fcγ receptor signaling
26. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells
27. sli-1, a negative regulator of let-23-mediated signaling in C. elegans
28. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl
29. The product of the protooncogene c-cbl: A negative regulator of the Syk tyrosine kinase
30. Cbl-mediated negative regulation of the Syk tyrosine kinase
31. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice
32. Altered thymic positive selection and intracellular signals in Cbl-deficient mice
33. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes
34. BLNK required for coupling Syk to PLCγ2 and Rac1-JNK in B cells
35. Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cγ, Grb2 and Vav after B cell antigen receptor activation
36. Association of phospholipase C-γ2 Src homology 2 domains with BLNK is critical for B cell antigen receptor signaling
37. SLP-65: A new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation
38. BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of fabricius
39. The complexity of signaling pathways activated by the BCR
40. Initiation and processing of signals from the B cell antigen receptor
41. Antigen receptor signaling: Integration of protein tyrosine kinase functions
42. Genetic analysis of B cell antigen receptor signaling
43. 2+ mobilization through distinct pathways
44. Evidence for an IgD homologue on chicken lymphocytes
45. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death
46. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement
47. 2+ indicators with greatly improved fluorescence properties
48. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
49. Requirement of phospholipase C-γ2 activation in surface immunoglobulin M-induced B cell apoptosis
50. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2
51. C-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
52. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor α
53. The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation
54. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
55. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor
56. Cloning and characterization of cbl-b: A SH3 binding protein with homology to the c-cbl proto-oncogene
57. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation
58. 3)/Tec kinase-dependent calcium signaling pathway: A target for SHIP-mediated inhibitory signals
59. 3: A regulatory nexus between tyrosine kinases and sustained calcium signals
60. Activation of phospholipase Cγ by PI 3-kinase-induced PH domain-mediated membrane targeting
61. BLNK: A central linker protein in B cell activation
62. SH2 domains recognize specific phosphopeptide sequences
63. Activation of nuclear factor of activated T cells-(NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk(L) or p85 phosphatidylinositol 3-kinase association
64. Dual regulation of T cell receptor-mediated signaling by oncogenie Cbl mutant 70Z
65. Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases
66. Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function
67. Enhancement of lymphocyte responsiveness by a gain-of-function mutation of ZAP-70